Boditech Med Inc. | Ownership

Companies that own Boditech Med Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BlackRock Fund Advisors
260,109
1.11%
0
0%
09/05/2018
Dimensional Fund Advisors LP
195,667
0.84%
0
0%
04/30/2018
Mirae Asset Global Investments Co., Ltd.
32,055
0.14%
8,689
0%
04/30/2018
BlackRock Advisors (UK) Ltd.
9,954
0.04%
0
0%
09/05/2018
TIAA-CREF Investment Management LLC
7,673
0.03%
0
0%
03/31/2018
Bessemer Investment Management LLC
1,467
0.01%
0
0%
04/30/2018
DFA Australia Ltd.
731
0%
731
0%
11/30/2017
Korea Investment Management Co., Ltd.
635
0%
635
0%
01/31/2017
Samsung Asset Management Co., Ltd.
477
0%
-191,275
0%
07/06/2018
UBS Asset Management (UK) Ltd.
149
0%
149
0%
12/29/2017

About Boditech Med

View Profile
Address
43 Geodudanji 1-gil
Chuncheon GA 24398
Korea, Republic Of
Employees -
Website http://www.boditech.co.kr
Updated 09/14/2018
Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. Its products include iChroma II Reader, AFIAS6, iChroma Reader, Ichroma D, i-Chamber, and hemochroma PLUS. It also provides cardiac, tumor, diabetes, hormone, infection and rheumatoid arthritics tests.